Bard Financial Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.83M | Sell |
69,970
-11,795
| -14% | -$814K | 0.58% | 52 |
|
|
2025
Q1 | $5.68M | Sell |
81,765
-3,625
| -4% | -$252K | 0.69% | 44 |
|
|
2024
Q4 | $7.35M | Sell |
85,390
-3,500
| -4% | -$301K | 0.88% | 28 |
|
|
2024
Q3 | $10.6M | Sell |
88,890
-8,275
| -9% | -$985K | 1.25% | 18 |
|
|
2024
Q2 | $13.9M | Buy |
97,165
+2,260
| +2% | +$323K | 1.43% | 13 |
|
|
2024
Q1 | $12.2M | Sell |
94,905
-2,475
| -3% | -$318K | 1.29% | 19 |
|
|
2023
Q4 | $10.1M | Buy |
97,380
+2,670
| +3% | +$276K | 1.13% | 21 |
|
|
2023
Q3 | $8.61M | Sell |
94,710
-3,600
| -4% | -$327K | 1.06% | 23 |
|
|
2023
Q2 | $7.95M | Sell |
98,310
-3,300
| -3% | -$267K | 0.6% | 45 |
|
|
2023
Q1 | $8.09M | Sell |
101,610
-3,000
| -3% | -$239K | 0.65% | 40 |
|
|
2022
Q4 | $7.08M | Sell |
104,610
-1,750
| -2% | -$118K | 0.6% | 45 |
|
|
2022
Q3 | $5.3M | Buy |
106,360
+500
| +0.5% | +$24.9K | 0.5% | 52 |
|
|
2022
Q2 | $5.9M | Sell |
105,860
-250
| -0.2% | -$13.9K | 0.54% | 50 |
|
|
2022
Q1 | $5.89M | Sell |
106,110
-1,000
| -0.9% | -$55.5K | 0.48% | 54 |
|
|
2021
Q4 | $6M | Sell |
107,110
-400
| -0.4% | -$22.4K | 0.48% | 56 |
|
|
2021
Q3 | $5.16M | Sell |
107,510
-200
| -0.2% | -$9.6K | 0.46% | 59 |
|
|
2021
Q2 | $4.51M | Sell |
107,710
-1,250
| -1% | -$52.4K | 0.4% | 64 |
|
|
2021
Q1 | $3.67M | Sell |
108,960
-11,000
| -9% | -$371K | 0.36% | 77 |
|
|
2020
Q4 | $4.19M | Buy |
+119,960
| New | +$4.19M | 0.42% | 63 |
|